The Lazarus Story

Lazarus Effect is building a powerful set of innovative intravascular products starting with the company’s unique cover technology.

Over the past 20 years, Martin Dieck, Brian Martin, and Y. Pierre Gobin, MD have teamed up to deliver more than 15 innovative vascular medical devices. These technologies have covered a broad range of applications, including embolization, thrombectomy and even improvements to basic catheter design. Their contributions have helped improve the overall performance and frequently expanded the reach of physicians into new areas of treatment. Fast forward to Lazarus Effect: Dieck, Martin and Gobin are pioneering medical technology once again.

M. Dieck, Co-Founder, Chairman, CEO

Martin Dieck co-founded Lazarus Effect, Inc., and currently serves as CEO and Chairman of the board. He previously was a founder and CEO of Nfocus Neuromedical. Nfocus developed a ‘single shot’ device to treat brain aneurysms and was acquired by Covidien in 2013. Previously Mr. Dieck co-founded and was President and CEO of Concentric Medical. Concentric developed the first device to treat ischemic stroke and was acquired by Stryker in 2011. He served as a senior executive at a medical device incubator, where he participated in the formation of four companies across diverse medical applications. Mr. Dieck was Co-Founder of Micro Interventional Systems. MIS built a suite of catheter products to address neurovascular applications and was acquired by Medtronic in 1996. In addition, Dieck is Executive Director of ePlanet Global Capital and is responsible for its life sciences portfolio. This portfolio is diversified across a wide variety of medical devices and includes 7 companies: 5 (including Nfocus Neuromedical) of which have exited to date for a combined value of over $600M. Mr. Dieck is also an inventor with over 30 issued and pending patents. He received his BA in Biological Sciences from Willamette University and MBA from the University of California at Berkeley.

 

B. Martin, Co-Founder, VP R&D

Brian Martin is a co-founder of Lazarus Effect Inc., and holds the position of Vice President, Research and Development. Mr. Martin has had numerous R&D positions over the last 23 years with several medical device companies, including both large organizations and small startups. Mr. Martin has experience developing medical devices in the fields of intracardiac, peripheral interventional, intracoronary, and neuro-internventional medicine. He has held R&D positions with Advanced Cardiovascular Systems/Guidant, Micro Interventional Systems, BioInterventional, and Evalve, Inc. Mr. Martin has specialized in early stage startups, and was first engineer in numerous startup companies, creating new technology platforms and leading projects to clinical debuts. Mr. Martin is an inventor or co-inventor on over 40 patents and published patent applications. Mr. Martin earned a B.S. in biomedical engineering from the University of California at San Diego.

Y. Gobin, MD, Co-Founder
Y. Pierre Gobin MD is an internationally recognized expert in the field of interventional neuroradiology, with 20 years of experience in the treatment of vascular diseases of the brain, head and neck, and spine. A pioneer in endovascular treatment of cerebral aneurysms, Dr. Gobin has also developed and established minimally invasive surgical approaches to treat acute strokes. Dr. Gobin completed his medical degree, internship and radiology residency at the University of Paris, France in 1988. He trained in interventional neuroradiology at Hospital Lariboisiere in Paris, where he performed the first GDC coil embolization in France, in a patient with a cerebral aneurysm. Dr. Gobin was recruited by the Division of Interventional Neuroradiology of the University of California at Los Angeles in 1992, and was a member of the faculty there for nine years.